# Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients

> **NCT01399957** · — · COMPLETED · sponsor: **Mount Sinai Rehabilitation Hospital** · enrollment: 52 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01399957
- **Lead sponsor:** Mount Sinai Rehabilitation Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2014-09
- **Final completion:** 2015-09
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2015-11-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01399957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01399957, "Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01399957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*